04.05.22
Jland Biotech (stand V132) says it is set to disrupt the market with the launch of Biollagen-Lipo. The new active combines Jland’s unique type 3 recombinant collagen, Biollagen, with the skin penetrating power of liposomes. Biollagen is made using Jland’s patented yeast fermentation technology. According to the company, it has the benefits of collagen with zero virus risk, low immunogenicity, no allergenicity, no rejection risk & good biocompatibility. Encapsulating Biollagen leads to superior performance. It has the obvious advantages of faster transdermal adsorption, stronger stability, slower release/longer acting, lower effective dose & reduced systemic adsorption, according to the company.
An independent skin penetration study carried out by a leading European laboratory compared Biollagenm SSE Lipo vs free Biollagen SSE. The study found that liposome encapsulation allows the Biollagen to penetrate the skin more efficiently, with 2.6 times more found in the epidermis after seven hours than free Biollagen.
More info: Jland Biotech, Website: en.jlandbiotech.com
An independent skin penetration study carried out by a leading European laboratory compared Biollagenm SSE Lipo vs free Biollagen SSE. The study found that liposome encapsulation allows the Biollagen to penetrate the skin more efficiently, with 2.6 times more found in the epidermis after seven hours than free Biollagen.
More info: Jland Biotech, Website: en.jlandbiotech.com